NasdaqGM - Nasdaq Real Time Price USD

Aimei Health Technology Co., Ltd (AFJK)

Compare
10.58 +0.04 (+0.38%)
At close: October 31 at 4:00 PM EDT
Loading Chart for AFJK
DELL
  • Previous Close 10.54
  • Open 10.54
  • Bid --
  • Ask --
  • Day's Range 10.54 - 10.58
  • 52 Week Range 10.15 - 10.60
  • Volume 1,257
  • Avg. Volume 15,398
  • Market Cap (intraday) 95.495M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AFJK

View More

Performance Overview: AFJK

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AFJK
4.13%
S&P 500
17.29%

1-Year Return

AFJK
4.13%
S&P 500
17.29%

3-Year Return

AFJK
4.13%
S&P 500
17.29%

5-Year Return

AFJK
4.13%
S&P 500
17.29%

Compare To: AFJK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AFJK

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    95.50M

  • Enterprise Value

    94.91M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    1.63M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    157.5k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AFJK

View More

Company Insights: AFJK

Research Reports: AFJK

View More

People Also Watch